Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Recce Pharmaceuticals Ltd. ( (AU:RCE) ).
Recce Pharmaceuticals Ltd. has announced a Key Opinion Leader event focused on their clinical data milestones, highlighting the company’s innovation journey. This announcement underscores Recce’s commitment to advancing its research and development efforts, potentially impacting its market position and offering insights into future strategic directions.
More about Recce Pharmaceuticals Ltd.
YTD Price Performance: -12.37%
Average Trading Volume: 114,882
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$98.55M
Learn more about RCE stock on TipRanks’ Stock Analysis page.